TRUST CO OF VERMONT - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,640
+5.9%
2000.0%0.00%
Q2 2023$7,214
-5.6%
2000.0%0.00%
-100.0%
Q1 2023$7,638
-32.9%
2000.0%0.00%0.0%
Q4 2022$11,380
+42.2%
2000.0%0.00%0.0%
Q3 2022$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2022$9,000
+12.5%
2000.0%0.00%0.0%
Q4 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2021$9,000
+12.5%
2000.0%0.00%0.0%
Q1 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q4 2020$9,000
+80.0%
2000.0%0.00%
Q3 2020$5,0000.0%2000.0%0.00%
Q2 2020$5,000
+25.0%
2000.0%0.00%
Q1 2020$4,0000.0%2000.0%0.00%
Q4 2019$4,000
+33.3%
2000.0%0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,0000.0%2000.0%0.00%
Q4 2018$3,000
-25.0%
2000.0%0.00%
Q3 2018$4,000
+33.3%
2000.0%0.00%
Q2 2018$3,000
-25.0%
2000.0%0.00%
Q1 2018$4,0000.0%2000.0%0.00%
Q4 2017$4,0002000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders